What is the global market size of Physician Dispensed Cosmeceuticals Market?

Physician Dispensed Cosmeceuticals Market was valued at USD 8.5 Billion in 2021, and USD 9.16 billion in 2022 and it is expected to reach a value of USD 16.7 Billion by 2030, at a CAGR of 7.8% over the forecast period (2023 - 2030).

Global Physician Dispensed Cosmeceuticals Market Size, Share, Growth Analysis, By Product Type(Skin Care, Hair Care), By Distribution Channel(Hospital Pharmacies, Retail Pharmacies) - Industry Forecast 2024-2031

Report ID: SQMIG35I2100 | Region: Global | Published Date: February, 2024
Pages: 157 | Tables: 64 | Figures: 68

Global Physician Dispensed Cosmeceuticals Market Insights

Physician Dispensed Cosmeceuticals Market was valued at USD 8.5 Billion in 2019, and USD 9.16 billion in 2019 and it is expected to reach a value of USD 16.7 Billion by 2031, at a CAGR of 7.8% over the forecast period (2024-2031).

Physician-dispensed cosmeceuticals are products that are only available through a medically guided company and are designed to produce true biological effects below the stratum corneum on the skin. Medicated aesthetic goods suggested by dermatologists, trichologists, cosmetic surgeons, and other medical practitioners are described as physician-dispensed cosmeceuticals.

The increased significance of beauty and appearance, as well as expanding knowledge of anti-aging, will drive demand for cosmeceuticals prescribed by doctors. Furthermore, rising consumer awareness of the safety and efficacy of physician-dispensed cosmeceuticals, as well as a growing preference among consumers for a specific solution to different skin problems such as age spot or acne spot reduction, are expected to drive market growth significantly over the forecast period. Government regulation, intense competition, and the larger availability of replacements are some of the significant factors that might limit market growth in the anticipated time.

US Physician Dispensed Cosmeceuticals Market is poised to grow at a sustainable CAGR for the next forecast year.

Global Physician Dispensed Cosmeceuticals Market Report Snapshots

License Type Top market research company in USA

File Type

$5,300

BUY NOW GET FREE SAMPLE

Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

The Global Physician Dispenced Cosmeceuticals market is relatively fragmented, with a high level of competition. Companies are working on new product launches and other initiatives to provide better equipment to their customers and expand their companies globally. These industry leaders are expanding their client base in a variety of ways, and many organizations are forming strategic and creative partnerships with other start-up businesses in order to increase market share and profitability. Due to the existence of numerous small and major producers, the market is somewhat competitive. Due to increased expenditures in R&D for product innovation and boosting product efficiency by bringing new items into the market, the market rivalry is fierce. Allergan, Merz Pharma, INNOVATIVE SKINCARE, Obagi Cosmeceuticals LLC, SkinCeuticals International, and others are key participants in the industry. 'Allergan Plc', 'SkinMedica, Inc.', 'Biopelle, Inc.', 'Clinique Laboratories, LLC', 'Cutera, Inc.', 'Emerson Ecologics, LLC', 'iS CLINICAL', 'Jan Marini Skin Research, Inc.', 'La Roche-Posay Laboratoire Pharmaceutique', 'Neutrogena Corp.', 'Obagi Medical Products, Inc.', 'SkinCeuticals', 'Stiefel Laboratories, Inc.'

The need for cosmeceuticals to eliminate visible aging indications is driven by a rise in personal maintenance awareness among the elderly population and changing views among the middle-aged and aging population in emerging nations.

SkinCeuticals, a pioneer in breakthrough skincare technologies, will launch Vivace Fractional Micro Needle Radio Frequency Procedure with SkinCeuticals C E Ferulic in October 2020, a minimally invasive skin rejuvenation treatment.

North America, Europe, Asia Pacific, and the Rest of the World make up the Global Physician Dispensed Cosmeceuticals Market. Over the projected period, the Asia Pacific market is predicted to increase considerably. In the area, there is a growing desire to see long-lasting young appearance and beauty, which is driving the demand for effective physician-dispensed cosmeceuticals. Furthermore, the Asia Pacific market will be driven by leading market players' increasing focus on expansion in Asia Pacific nations, the region's large consumer base, and increased awareness of physician-dispensed cosmeceuticals.

Feedback From Our Clients

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

Global Physician Dispensed Cosmeceuticals Market Size, Share, Growth Analysis, By Product Type(Skin Care, Hair Care), By Distribution Channel(Hospital Pharmacies, Retail Pharmacies) - Industry Forecast 2024-2031

Global Physician Dispensed Cosmeceuticals Market Insights

Global Physician Dispensed Cosmeceuticals Market Report Snapshots

Want to customize this report?

FAQs

What is the global market size of Physician Dispensed Cosmeceuticals Market?

Who are the key vendors in the Global Physician Dispensed Cosmeceuticals Market?

What is the key driver of Global Physician Dispensed Cosmeceuticals Market?

What is the key market trend for Global Physician Dispensed Cosmeceuticals Market?

Which region accounted for the largest share in Global Physician Dispensed Cosmeceuticals Market?

Request Free Customization

Related Reports

Feedback From Our Clients

$5,300